Abstract Background and aims Despite numerous trials, the optimal design of stroke aftercare programs remains unclear. The StroCare trial evaluated a structured, transitional and follow-up care program to improve health-related quality of life (HRQoL) up to 2 years after stroke but found no overall intervention effect. This post-hoc analysis explored whether treatment effects differed across patient characteristics. Methods At 12 and 24 months we fitted timepoint-specific linear regression models for PROMIS-10 Global Physical Health T-scores including interaction terms between treatment group and covariates prespecified in the main analysis. Interactions were examined individually and jointly in the intention-to-treat population using multiple imputation with pooled estimates for missing data, analogous to the main analysis. Results Pre-existing care level was strongly associated with worse HRQoL at 12 (ß=-3.8; p0.0001) and 24 months (ß=-3.8; p0.0001). Single-interaction models indicated a stronger attenuation of this negative association in the intervention group at 12 months (group x care level ß=2.4; p=0.03) and a similarly directed but weaker trend at 24 months (ß=2.0; p=0.066). In the full interaction model, this interaction was weaker (12 months: ß=2.2; p=0.058; 24 months: ß=1.7; p=0.13). No other covariates showed relevant effect moderation. Conclusions Given the post-hoc design and small proportion of patients with higher care levels in the study population, these results should be interpreted as hypothesis-generating. However, they suggest that structured aftercare programs may confer greater benefit in more dependent stroke survivors, a subpopulation underrepresented in aftercare trials. We therefore deem the targeted evaluation of such programs in this subpopulation in future trials warranted. Conflict of interest Bourry, Rafael: Nothing to disclose; Petter, Jonas: Nothing to disclose; Schrage, Theresa: Nothing to disclose; Molder, Janina: Nothing to disclose; Boskamp, Stefan: Nothing to disclose; Härter, Martin: Sourced funding with the Innovation Fund of the German Federal Joint Committee; Rosenkranz, Michael: Nothing to disclose; Schmidt, Holger: Nothing to disclose; Beisel, Andreas: Nothing to Disclose; Dams, Judith: Nothing to Disclose; König, Hans-Helmut: Nothing to disclose; Kriston, Levente: Sourced funding with the Innovation Fund of the German Federal Joint Committee; Thomalla, Götz: Sourced funding with the Innovation Fund of the German Federal Joint Committee
Building similarity graph...
Analyzing shared references across papers
Loading...
Rafael Bourry
Jonas Petter
Theresa Schrage
European Stroke Journal
Universität Hamburg
University Medical Center Hamburg-Eppendorf
Elbe Kliniken Stade-Buxtehude
Building similarity graph...
Analyzing shared references across papers
Loading...
Bourry et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69fd7ec6bfa21ec5bbf0716d — DOI: https://doi.org/10.1093/esj/aakag023.1066